Učitavanje...
Bispecific small molecule–antibody conjugate targeting prostate cancer
Bispecific antibodies, which simultaneously target CD3 on T cells and tumor-associated antigens to recruit cytotoxic T cells to cancer cells, are a promising new approach to the treatment of hormone-refractory prostate cancer. Here we report a site-specific, semisynthetic method for the production o...
Spremljeno u:
| Glavni autori: | , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
National Academy of Sciences
2013
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3816437/ https://ncbi.nlm.nih.gov/pubmed/24127589 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1316026110 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|